umeclidinium
umeclidinium is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Umeclidinium Ellipta, Incruse Ellipta. Available dosage form: aerosol, powder.
Drug details
- Generic Name
- umeclidinium
- Brand Names
- Umeclidinium Ellipta, Incruse Ellipta
- Application Number
- NDA205382
- Sponsor
- Prasco Laboratories
- NDC Codes
- 2
- Dosage Forms
- AEROSOL, POWDER
- Routes
- ORAL
- Active Ingredients
- UMECLIDINIUM BROMIDE
Indications and Usage
1 INDICATIONS AND USAGE Umeclidinium ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Umeclidinium ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 )